SHERIDAN, WYOMING – May 11, 2025 – At ProPak Asia 2025, Sidel is set to highlight its leadership in aseptic packaging and smart production technologies, showcasing cutting-edge solutions that drive operational efficiency, sustainability, and product safety for beverage and liquid food manufacturers across Southeast Asia.

From Booth AB06 in Hall 101, Sidel will demonstrate the transformative capabilities of its Aseptic Combi Predis™ system, a patented dry preform sterilisation solution for PET bottles. Alongside this flagship innovation, visitors will discover integrated line solutions, advanced quality control with IntelliADJUST™, and the Evo-ON® digital suite for real-time performance optimisation—each designed to meet the fast-evolving demands of modern production environments.

Leading the Way in Aseptic Packaging

SHERIDAN, WYOMING – May 11, 2025 – Sidel has unveiled the EvoFILL Can Compact, a compact, high-performance filling system engineered to meet the dynamic needs of premium beverage producers. Purpose-built for low-to-medium speed operations, this new solution is strategically designed to support flexibility, efficiency, and precision across a wide range of applications, from beer to carbonated soft drinks (CSDs), and even hot fill products.

As global beverage production surges—with alcoholic beverage volumes forecast to reach 492.1 billion units and non-alcoholic packaging expected to exceed 1.3 trillion units by 2028—demand for space-saving, multi-purpose filling solutions continues to grow. The EvoFILL Can Compact directly addresses this market need, offering a versatile, hygienic, and modular system for producers seeking to manage SKU complexity while maintaining operational excellence.

SHERIDAN, WYOMING – May 11, 2025 – Dentsply Sirona, in partnership with the American Association for Dental, Oral and Craniofacial Research (AADOCR), has officially announced the winners of the 2025 Student Competition for Advancing Dental Research and its Application (SCADA) Awards. Unveiled during the Opening Ceremonies of the 54th AADOCR Annual Meeting in New York, the awards spotlight student-led research poised to shape the future of oral healthcare innovation.

Highlighting Student Research Excellence in Dental Science

The SCADA Awards, a globally recognized platform for emerging dental researchers, continue to elevate promising talent within clinical, public health, basic, and translational science disciplines. This year’s winners were selected from top-tier dental schools across the United States and honored for their research addressing key challenges and advancements in dentistry.

SHERIDAN, WYOMING – May 9, 2025 – LivaNova PLC, a global leader in medical technology, announced strong first-quarter 2025 results today, demonstrating continued growth and operational efficiency. The company reported high single-digit revenue growth, including double-digit organic revenue increases, as well as expanding operating margins. LivaNova also raised its full-year 2025 revenue guidance, taking into account the impact of the SNIA environmental liability and current tariffs.

Strong Financial Performance in Q1 2025

For the first quarter of 2025, LivaNova recorded total revenue of $316.9 million, a 7.4% increase compared to the same period in 2024. On a constant-currency basis, revenue grew by 8.9%, with organic revenue expanding by 10.4%. Key drivers of growth included strong demand in the Cardiopulmonary and Neuromodulation segments, as well as increased sales from the Essenz™ Perfusion System and cardiopulmonary consumables.

SHERIDAN, WYOMING – May 9, 2025 – LivaNova PLC, a leading global medical technology company, has announced 12-month top-line data from its OSPREY clinical trial. The study demonstrates promising results for the aura6000™ System, an investigational device designed to treat moderate to severe obstructive sleep apnea (OSA). The data highlights sustained improvements in key health metrics, positioning the aura6000™ as a potential breakthrough in OSA management.

Strong Results from 12-month OSPREY Data

The OSPREY trial's 12-month data shows significant improvements for patients receiving the aura6000™ System, demonstrating the effectiveness of proximal hypoglossal nerve stimulation (p-HGNS) in managing OSA. The results confirm the system’s potential as a long-term solution for patients with moderate to severe cases who have previously struggled with conventional treatments.

Key highlights from the study include:

SHERIDAN, WYOMING – May 09, 2025 – Globus Medical, Inc. (NYSE: GMED), a leading provider of musculoskeletal solutions, has announced its financial results for the first quarter of 2025. The company reported worldwide net sales of $598.1 million, reflecting a 1.4% decrease year-over-year, primarily driven by a slowdown in Enabling Technology deal closures and temporary supply chain disruptions. Despite these challenges, Globus Medical saw notable growth in its core U.S. spine business and remains optimistic about its future prospects.

SHERIDAN, WYOMING – May 9, 2025 – Globus Medical, Inc. (NYSE: GMED), a prominent player in the musculoskeletal solutions industry, has reported its financial results for the first quarter of 2025. Despite a slight dip in global net sales, the company remains confident in its ability to drive long-term growth and innovation. The results reflect challenges faced in certain areas, including slower deal closures in Enabling Technology, but also showcase the company’s strong positioning in the U.S. spine business.

SHERIDAN, WYOMING – May 9, 2025 – Enovis Corporation (NYSE: ENOV), a global leader in medical technology, has appointed Damien McDonald as its new Chief Executive Officer, effective May 12, 2025. McDonald, who will also join the Enovis Board of Directors following the Company’s 2025 Annual Meeting of Stockholders, succeeds Matt Trerotola, who has announced his retirement. This strategic leadership transition positions Enovis for continued growth and innovation in the medical technology sector.

SHERIDAN, WYOMING – May 8, 2025 – Invacare is proud to announce the launch of its global fundraiser, Move For Mobility 2025, which aims to provide life-changing wheelchairs to individuals in need around the world. The initiative brings together Invacare employees, ambassadors, clients, and partners in a worldwide effort to raise awareness and funds for the Free Wheelchair Mission, an organization committed to delivering wheelchairs at no cost to people with disabilities in remote communities.

A Strong Partnership with Free Wheelchair Mission

Since its inception, Invacare has partnered with Free Wheelchair Mission, a humanitarian non-profit organization, to help deliver mobility solutions to underserved populations globally. This year marks the sixth year of this partnership, with Invacare contributing its engineering, testing, and distribution expertise to help create durable and effective wheelchairs.

SHERIDAN, WYOMING – May 8, 2025 – SEALPAC is set to spotlight its new A6max traysealer at IFFA 2025, presenting a game-changing innovation in automated packaging under its #SealingTheFuture campaign. Designed to meet evolving industry demands around sustainability, efficiency, and product diversity, the A6max highlights the universal versatility of SEALPAC’s Amax-series and marks a strategic leap forward for food producers across traditional and alternative protein segments.

Operational Excellence for a Dynamic Market

The SEALPAC A6max is engineered to deliver maximum process reliability from denesting to sealing, ensuring high-quality output even at elevated production speeds. It’s built to address the operational pressures of modern food manufacturing, offering: